Drug Profile
Research programme: cancer therapeutics and diagnostics - OncoTAb
Alternative Names: Monoclonal antibody - OncoTAb; TAB 004Latest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator OncoTAb
- Class Antibodies; Antibody diagnostics; Diagnostic agents; Radiopharmaceuticals
- Mechanism of Action Diagnostic imaging enhancers; Mucin 1 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Breast cancer; Pancreatic cancer
Highest Development Phases
- No development reported Breast cancer; Pancreatic cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Breast-cancer in USA (Parenteral)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Breast-cancer(Diagnosis) in USA (Parenteral)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Pancreatic-cancer in USA (Parenteral)